IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
178.81
+8.17 (4.79%)
At close: Feb 27, 2026, 4:00 PM EST
175.52
-3.29 (-1.84%)
Pre-market: Mar 2, 2026, 7:03 AM EST
IQVIA Holdings Employees
IQVIA Holdings had 93,000 employees as of December 31, 2025. The number of employees increased by 5,000 or 5.68% compared to the previous year.
Employees
93,000
Change (1Y)
5,000
Growth (1Y)
5.68%
Revenue / Employee
$175,376
Profits / Employee
$14,624
Market Cap
30.02B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 93,000 | 5,000 | 5.68% |
| Dec 31, 2024 | 88,000 | 1,000 | 1.15% |
| Dec 31, 2023 | 87,000 | 1,000 | 1.16% |
| Dec 31, 2022 | 86,000 | 7,000 | 8.86% |
| Dec 31, 2021 | 79,000 | 9,000 | 12.86% |
| Dec 31, 2020 | 70,000 | 3,000 | 4.48% |
| Dec 31, 2019 | 67,000 | 9,000 | 15.52% |
| Dec 31, 2018 | 58,000 | 3,000 | 5.45% |
| Dec 31, 2017 | 55,000 | 5,000 | 10.00% |
| Dec 31, 2016 | 50,000 | 13,900 | 38.50% |
| Dec 31, 2015 | 36,100 | 3,500 | 10.74% |
| Dec 31, 2014 | 32,600 | 4,400 | 15.60% |
| Dec 31, 2013 | 28,200 | 788 | 2.87% |
| Dec 31, 2012 | 27,412 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| Mettler-Toledo International | 18,100 |
| Agilent Technologies | 18,100 |
| IDEXX Laboratories | 11,000 |
| Illumina | 10,080 |
| Waters | 7,900 |
| Exact Sciences | 7,200 |
IQV News
- 2 days ago - IQVIA Holdings: Still Exceeding Expectations As A Stealth Compounder - Seeking Alpha
- 2 days ago - IQVIA Releases its 2025 Sustainability Report - Business Wire
- 3 days ago - IQVIA Holdings Inc. (IQV) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript - Seeking Alpha
- 5 days ago - IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities - Business Wire
- 5 days ago - 10 stocks Wall Street expects to roar back after dropping at least 20% in 2026 - Market Watch
- 11 days ago - IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day - Business Wire
- 18 days ago - Oakmark Global All Cap Strategy Q4 2025 Performance Review - Seeking Alpha
- 20 days ago - IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions - Business Wire